GlassScriptPhysician profile
Kathryn L Davis
NPI 1871791301
$2,334.00
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,205 · 2020: $244 · 2022: $342 · 2023: $393 · 2024: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $543.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $542.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $1,003.50 | 2019 | |
| Endologix LLC | $727.35 | 2022-2024 | Alto Abdominal Stent Graft System, Afx2 Bifurcated Endograft System |
| W. L. Gore & Associates, INC. | $269.09 | 2019-2020 | |
| Penumbra, INC. | $149.02 | 2023 | Indigo System |
| Bard Peripheral Vascular, INC. | $44.41 | 2020 | |
| Kerecis Limited | $24.49 | 2020-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Nuvasive, INC. | $23.86 | 2020 | |
| Cardiva Medical, INC. | $17.21 | 2019 | |
| Janssen Pharmaceuticals, INC | $16.06 | 2020 | |
| Terumo Medical Corporation | $15.81 | 2019 | |
| Covidien LP | $15.44 | 2019 | |
| Pfizer INC. | $14.07 | 2019 | |
| Allergan, INC. | $13.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathryn Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.